Related Experiment Video
Updated: Sep 13, 2025

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Comparative Mortality and Risk Analysis in Mucormycosis Cases: Pre-Pandemic Versus COVID-19 Association
Masoud Janipour1, Alireza Shahriari1, Ali Faramarzi1,2
1Otolaryngology Research Center, Department of Otolaryngology, Shiraz University of Medical Sciences, Shiraz, Iran.
COVID-19-associated mucormycosis (CAM) shows higher mortality and risk factors like diabetes and hypertension compared to pre-pandemic cases. Malignancies and high platelet counts predict mortality in CAM patients, necessitating aggressive management.
Area of Science:
- Infectious Diseases
- Epidemiology
- Mycology
Background:
- Mucormycosis is a serious fungal infection, with COVID-19 potentially increasing its incidence and severity.
- Understanding the clinical differences and risk factors between COVID-19-associated mucormycosis (CAM) and pre-pandemic mucormycosis is crucial for patient outcomes.
Purpose of the Study:
- To compare clinical profiles, outcomes, and mortality risk factors of CAM with pre-pandemic mucormycosis.
- To evaluate the impact of the COVID-19 pandemic on mucormycosis epidemiology and severity.
Main Methods:
- A retrospective, observational study was conducted across multiple medical centers.
- Clinical data of 122 mucormycosis patients (85 with CAM) were reviewed.
- Logistic regression analysis identified mortality predictors in CAM patients.
Main Results:
- CAM patients had higher rates of diabetes mellitus and hypertension than pre-pandemic cases.
- In-hospital mortality was significantly higher in CAM cases (23.1%) versus pre-pandemic cases (7.7%).
- Elevated platelet counts and periorbital edema were more common in CAM; malignancies and high platelets predicted mortality.
Conclusions:
- The COVID-19 pandemic has increased the severity and mortality of mucormycosis.
- CAM cases exhibit worse outcomes compared to pre-pandemic mucormycosis.
- Aggressive management and awareness of risk factors are vital for improving survival in CAM patients.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Relative Risk
Cancer Survival Analysis
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The Mantel-Cox Log-Rank Test
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

